Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 193 institutions reported holding it in 13F filings for Q2 2026, worth $647.3M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2026
Institutional positions in Esperion Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ESPR is no longer listed, and 13F filings after Q2 2026 list far fewer holders. See Q2 2026
- Institutional holders
- 2
- −186 vs. Q2 2026
- Shares held
- 1.03K
- −205.0M (−100.0%) vs. Q2 2026
- Total value
- $355
- −$646.1M (−100.0%) vs. Q2 2026
- New holders
- 1
- 0 more added
- Sold out
- 187
- 0 more reduced
5 institutions that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ESPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 2 | $355 |
| Q2 2026 | 193 | $647.3M |
| Q1 2026 | 209 | $479.3M |
| Q4 2025 | 201 | $559.6M |
| Q3 2025 | 189 | $286.1M |
| Q2 2025 | 164 | $96.6M |
| Q1 2025 | 187 | $171.5M |
| Q4 2024 | 190 | $277.9M |
| Q3 2024 | 184 | $214.3M |
| Q2 2024 | 176 | $304.2M |
| Q1 2024 | 153 | $336.2M |
| Q4 2023 | 132 | $215.3M |
| Q3 2023 | 123 | $75.9M |
| Q2 2023 | 124 | $103.6M |
| Q1 2023 | 165 | $129.1M |
| Q4 2022 | 164 | $457.6M |
| Q3 2022 | 148 | $425.5M |
| Q2 2022 | 137 | $352.1M |
| Q1 2022 | 132 | $241.2M |
| Q4 2021 | 133 | $268.0M |
| Q3 2021 | 139 | $299.4M |
| Q2 2021 | 142 | $599.4M |
| Q1 2021 | 156 | $805.3M |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Esperion Therapeutics, Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Glenmede Trust Co NA | 134 | $355 | 0.00% | +134 | New |
| Asset Planning,Inc | 900 | $0 | 0.00% | 00.0% | Unchanged |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −22,416,339−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −22,128,021−100.0% | Sold out |
| Vanguard Capital Management LLC | 0 | $0 | 0.00% | −11,427,437−100.0% | Sold out |
| Trium Capital LLP | 0 | $0 | 0.00% | −11,158,150−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,380,646−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −7,276,249−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −7,126,739−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −6,629,966−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −6,046,463−100.0% | Sold out |
| Oddo BHF Asset Management SAS | 0 | $0 | 0.00% | −5,000,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −4,654,778−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −4,612,705−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −4,431,598−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −3,884,508−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,836,202−100.0% | Sold out |
| PSquared Asset Management AG | 0 | $0 | 0.00% | −3,300,000−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −3,587,702−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −2,955,920−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −2,878,952−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −2,587,840−100.0% | Sold out |
| Vanguard Portfolio Management LLC | 0 | $0 | 0.00% | −2,471,671−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −2,321,824−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −2,315,900−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −2,225,733−100.0% | Sold out |
| Sagefield Capital LP | 0 | $0 | 0.00% | −2,190,108−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −2,107,733−100.0% | Sold out |
| Wasatch Advisors Inc | 0 | $0 | 0.00% | −1,930,185−100.0% | Sold out |
| Vanguard Fiduciary Trust Co | 0 | $0 | 0.00% | −1,737,509−100.0% | Sold out |
| Carmignac Gestion | 0 | $0 | 0.00% | −1,659,399−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −1,607,177−100.0% | Sold out |
| Transmarket Holdings LP | 0 | $0 | 0.00% | −1,590,721−100.0% | Sold out |
| Groupe la Francaise | 0 | $0 | 0.00% | −1,562,580−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −1,548,990−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −1,508,892−100.0% | Sold out |
| Alpine Associates Management Inc. | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,396,857−100.0% | Sold out |
| Gardner Lewis Asset Management L P | 0 | $0 | 0.00% | −1,365,251−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −1,265,010−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −1,244,100−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −1,141,740−100.0% | Sold out |
| Credit Industriel Et Commercial | 0 | $0 | 0.00% | −1,044,420−100.0% | Sold out |
| Absolute Gestao de Investimentos Ltda. | 0 | $0 | 0.00% | −997,000−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −930,160−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −847,118−100.0% | Sold out |
| Chicago Capital Management, LLC | 0 | $0 | 0.00% | −830,935−100.0% | Sold out |
| Vestcor Inc | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −757,358−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −742,245−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −732,616−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −700,670−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −657,441−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −612,774−100.0% | Sold out |
| Nuveen, LLC | 0 | $0 | 0.00% | −574,806−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −550,011−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −517,553−100.0% | Sold out |
| Mint Tower Capital Management B.V. | 0 | $0 | 0.00% | −503,300−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −502,200−100.0% | Sold out |
| Summit Wealth Group, LLC | 0 | $0 | 0.00% | −499,708−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −466,632−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −462,386−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −461,649−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −456,478−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −450,625−100.0% | Sold out |
| Burkehill Global Management, LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Kintayl Capital LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −384,261−100.0% | Sold out |
| Equitec Proprietary Markets, LLC | 0 | $0 | 0.00% | −345,800−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −329,091−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −305,675−100.0% | Sold out |
| JBF Capital, Inc. | 0 | $0 | 0.00% | −284,259−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −273,734−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −271,769−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −266,396−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −252,050−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −242,645−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −219,777−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −213,636−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −207,293−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −172,500−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −171,250−100.0% | Sold out |
| CIBRA Capital Ltd | 0 | $0 | 0.00% | −164,614−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −160,493−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −160,200−100.0% | Sold out |
| Eleva Capital SAS | 0 | $0 | 0.00% | −183,047−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −148,375−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −135,487−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −127,028−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −121,711−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −119,340−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −116,595−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −104,790−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −94,911−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −85,881−100.0% | Sold out |
| Summit Financial, LLC | 0 | $0 | 0.00% | −85,738−100.0% | Sold out |
| T3 Companies, LLC | 0 | $0 | 0.00% | −82,500−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −77,434−100.0% | Sold out |